AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 27349416 — intervention group
Group type: EXPERIMENTAL
Intervention: Anxiety and depression (Hospital Anxiety and Depression Scale; HADS)
Number of subjects: 81
Study 27349416 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient Benefit Index (PBI)
Number of subjects: 81
Study 26108426 — intervention group
Group type: EXPERIMENTAL
Intervention: Nanofilled FRCs after oven postcuring
Number of subjects: 80
Study 26108426 — intervention group
Group type: COMPARATOR
Intervention: Conventional FRCs after hand light-curing
Number of subjects: 80
Study 26108426 — intervention group
Group type: COMPARATOR
Intervention: 0.6-mm FRCs
Number of subjects: 80
Study 24035531 — intervention group
Group type: EXPERIMENTAL
Intervention: BCI-C (Breast-Cancer Index - Cubic)
Number of subjects: 665
Study 24035531 — intervention group
Group type: EXPERIMENTAL
Intervention: BCI-L (Breast-Cancer Index - Linear)
Number of subjects: 665
Study 24035531 — intervention group
Group type: EXPERIMENTAL
Intervention: 21-gene recurrence score
Number of subjects: 665
Study 24035531 — intervention group
Group type: EXPERIMENTAL
Intervention: IHC4
Number of subjects: 665
Study 20734082 — intervention group
Group type: EXPERIMENTAL
Intervention: Endoscopic ultrasonography (EUS)
Number of subjects: 515
Study 18171334 — intervention group
Group type: EXPERIMENTAL
Intervention: Intramuscular antivenom (one or two vials)
Number of subjects: 20
Study 18171334 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous antivenom (one vial or two or more vials)
Number of subjects: 20
Study 16879942 — intervention group
Group type: EXPERIMENTAL
Intervention: 150 ml, 240 mg/ml at 4 ml/s
Number of subjects: 120
Study 16879942 — intervention group
Group type: EXPERIMENTAL
Intervention: 120 ml, 300 mg/ml at 4 ml/s
Number of subjects: 120
Study 16879942 — intervention group
Group type: EXPERIMENTAL
Intervention: 97.3 ml, 370 mg/ml at 4 ml/s
Number of subjects: 120
Study 16879942 — intervention group
Group type: EXPERIMENTAL
Intervention: 150 ml, 240 mg/ml at 5 ml/s
Number of subjects: 120
Study 16879942 — intervention group
Group type: EXPERIMENTAL
Intervention: 120 ml, 300 mg/ml, 60 ml at 6 ml/s, 60 ml at 3 ml/s
Number of subjects: 120
Study 16879942 — intervention group
Group type: EXPERIMENTAL
Intervention: 97.3 ml, 370 mg/ml at 3.3 ml/s
Number of subjects: 120
Study 16879942 — intervention group
Group type: COMPARATOR
Intervention: Constant iodine administration rates (groups II, IV and VI)
Number of subjects: 120
Study 12807165 — intervention group
Group type: EXPERIMENTAL
Intervention: Budesonide inhalation powder (Pulmicort Turbuhaler), 100-800 microg b.i.d. for 52 weeks
Number of subjects: 1133
Study 12807165 — intervention group
Group type: EXPERIMENTAL
Intervention: Budesonide inhalation powder (Pulmicort Turbuhaler)
Number of subjects: 1133
Study 10890303 — intervention group
Group type: EXPERIMENTAL
Intervention: Enough Snuff self-help manual and a video
Number of subjects: 198
Study 10890303 — intervention group
Group type: EXPERIMENTAL
Intervention: LifeSign, a credit card-sized computer designed for gradual ST cessation
Number of subjects: 198
Study 8888715 — intervention group
Group type: EXPERIMENTAL
Intervention: Telenzepine (M1‐muscarinic receptor antagonist)
Number of subjects: 8
Study 8888715 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study 1891575 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychodynamic, time-limited group therapy
Number of subjects: 46
Study 6846235 — intervention group
Group type: EXPERIMENTAL
Intervention: Se-rich wheat (200 micrograms Se/day)
Number of subjects: 30
Study 6846235 — intervention group
Group type: EXPERIMENTAL
Intervention: Se-rich yeast (200 micrograms Se/day)
Number of subjects: 30
Study 6846235 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium selenate (200 micrograms Se/day)
Number of subjects: 30
Study 6846235 — intervention group
Group type: COMPARATOR
Intervention: Control group (unsupplemented subjects, N=20)
Number of subjects: 30
Study 30245148 — intervention group
Group type: EXPERIMENTAL
Intervention: Eribulin plus cyclophosphamide (ErC)
Number of subjects: 76
Study 30245148 — intervention group
Group type: COMPARATOR
Intervention: Docetaxel plus cyclophosphamide (TC)
Number of subjects: 76
Study 30245148 — intervention group
Group type: COMPARATOR
Intervention: Both ErC and TC
Number of subjects: 76
Study 30131266 — intervention group
Group type: EXPERIMENTAL
Intervention: Structure (S) condition
Number of subjects: 127
Study 30131266 — intervention group
Group type: EXPERIMENTAL
Intervention: Book metaphor (BM) condition
Number of subjects: 127
Study 30131266 — intervention group
Group type: EXPERIMENTAL
Intervention: Post organizer (PO) condition
Number of subjects: 127
Study 30131266 — intervention group
Group type: COMPARATOR
Intervention: Natural conversation (NC) condition
Number of subjects: 127
Study 28531784 — intervention group
Group type: EXPERIMENTAL
Intervention: BB (Barley kernel bread)
Number of subjects: 21
Study 28531784 — intervention group
Group type: EXPERIMENTAL
Intervention: BB-pro (Barley kernel bread with probiotics)
Number of subjects: 21
Study 28531784 — intervention group
Group type: COMPARATOR
Intervention: WWB-ref (White wheat flour based bread)
Number of subjects: 21
Study 24667038 — intervention group
Group type: EXPERIMENTAL
Intervention: Femtosecond laser in situ keratomileusis (FS-LASIK) with a side-cut angle of 115°
Number of subjects: 48
Study 24667038 — intervention group
Group type: COMPARATOR
Intervention: Femtosecond laser in situ keratomileusis (FS-LASIK) with a side-cut angle of 70°
Number of subjects: 48
Study 23005039 — intervention group
Group type: EXPERIMENTAL
Intervention: Melatonin (1 mg)
Number of subjects: 21
Study 20521324 — intervention group
Group type: EXPERIMENTAL
Intervention: Lorazepam (acute dose)
Number of subjects: 0
Study 20521324 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 17908851 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-speed handpiece with prophylaxis angles
Number of subjects: 20
Study 15611488 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture
Number of subjects: 135
Study 15611488 — intervention group
Group type: COMPARATOR
Intervention: Placebo (mock transcutaneous electrical stimulation)
Number of subjects: 135
Study 9714995 — intervention group
Group type: EXPERIMENTAL
Intervention: Methyldopa
Number of subjects: 30
Study 9714995 — intervention group
Group type: EXPERIMENTAL
Intervention: Isradipine
Number of subjects: 30
Study 9714995 — intervention group
Group type: COMPARATOR
Intervention: Control (Normal Pregnancy)
Number of subjects: 30
Study 8038589 — intervention group
Group type: EXPERIMENTAL
Intervention: Double perfusion schedule with melphalan (6 mg/l limb volume for first perfusion, 9 mg/l for second perfusion, normothermic, 1 hour duration, 3-4 weeks interval)
Number of subjects: 87
Study 8038589 — intervention group
Group type: COMPARATOR
Intervention: Single perfusion procedure with melphalan (10 mg/l, normothermic, 1 hour duration)
Number of subjects: 87
Study 8038589 — intervention group
Group type: EXPERIMENTAL
Intervention: Double perfusion schedule
Number of subjects: 87
Study 8038589 — intervention group
Group type: COMPARATOR
Intervention: Single perfusion procedure
Number of subjects: 87
Study 2498532 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravesical mitomycin C (40 mg)
Number of subjects: 43
Study 2498532 — intervention group
Group type: COMPARATOR
Intervention: Control group (conventional follow-up)
Number of subjects: 43
Study 949902 — intervention group
Group type: EXPERIMENTAL
Intervention: gefarnate (600 mg daily)
Number of subjects: 32
Study 949902 — intervention group
Group type: COMPARATOR
Intervention: dummy treatment
Number of subjects: 32
Study 949902 — intervention group
Group type: EXPERIMENTAL
Intervention: gefarnate
Number of subjects: 32
Study 30531772 — intervention group
Group type: EXPERIMENTAL
Intervention: Venarus and compression therapy
Number of subjects: 100
Study 30531772 — intervention group
Group type: COMPARATOR
Intervention: Compression therapy alone
Number of subjects: 100
Study 27317972 — intervention group
Group type: EXPERIMENTAL
Intervention: Mushroom-substituted carne asada
Number of subjects: 147
Study 27317972 — intervention group
Group type: COMPARATOR
Intervention: Taco blend recipes with full sodium
Number of subjects: 147
Study 27317972 — intervention group
Group type: EXPERIMENTAL
Intervention: Mushroom-containing recipes
Number of subjects: 147
Study 27317972 — intervention group
Group type: EXPERIMENTAL
Intervention: Reduced-sodium recipes
Number of subjects: 147
Study 27317972 — intervention group
Group type: COMPARATOR
Intervention: Full-sodium recipes
Number of subjects: 147
Study 24956066 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness training (MT)
Number of subjects: 0
Study 24956066 — intervention group
Group type: COMPARATOR
Intervention: Active control training (ACT)
Number of subjects: 0
Study 22531825 — intervention group
Group type: EXPERIMENTAL
Intervention: Anatomical decomposition of movement (elbow flexion/extension and unified shoulder motion)
Number of subjects: 3
Study 22531825 — intervention group
Group type: EXPERIMENTAL
Intervention: Euler decomposition of movement (three component shoulder motions in Euler coordinates and elbow flexion/extension)
Number of subjects: 3
Study 22531825 — intervention group
Group type: EXPERIMENTAL
Intervention: Visual decomposition of movement (motion of the tip of the elbow and motion of the hand with respect to the elbow)
Number of subjects: 3
Study 22531825 — intervention group
Group type: COMPARATOR
Intervention: Control group practicing the target motion only
Number of subjects: 3
Study 19737089 — intervention group
Group type: EXPERIMENTAL
Intervention: PHD inhibitors
Number of subjects: 0
Study 19737089 — intervention group
Group type: COMPARATOR
Intervention: Ischemic or hypoxic preconditioning
Number of subjects: 0
Study 18712455 — intervention group
Group type: COMPARATOR
Intervention: Standard intramedullary femoral instruments (IM group)
Number of subjects: 100
Study 18712455 — intervention group
Group type: EXPERIMENTAL
Intervention: New extramedullary device (EM group)
Number of subjects: 100
Study 15933281 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioral treatment implemented three times per week for 20 to 30 min each session for 3 months
Number of subjects: 20
Study 15933281 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 20
Study 15933281 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioral treatment
Number of subjects: 20
Study 12783289 — intervention group
Group type: EXPERIMENTAL
Intervention: Ibandronate (2 or 4 mg)
Number of subjects: 72
Study 12783289 — intervention group
Group type: COMPARATOR
Intervention: Pamidronate (15, 30, 60, or 90 mg)
Number of subjects: 72
Study 10943910 — intervention group
Group type: EXPERIMENTAL
Intervention: Dextromethorphan (non-competitive NMDA antagonist)
Number of subjects: 30
Study 10943910 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study 8669652 — intervention group
Group type: EXPERIMENTAL
Intervention: Rocuronium
Number of subjects: 0
Study 8669652 — intervention group
Group type: COMPARATOR
Intervention: Atracurium
Number of subjects: 0
Study 8669652 — intervention group
Group type: COMPARATOR
Intervention: Vecuronium
Number of subjects: 0
Study 1644724 — intervention group
Group type: EXPERIMENTAL
Intervention: Nortriptyline (not specified dosage or duration)
Number of subjects: 12
Study 1644724 — intervention group
Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 12
Study 6131825 — intervention group
Group type: EXPERIMENTAL
Intervention: Quazepam 15 mg
Number of subjects: 100
Study 6131825 — intervention group
Group type: EXPERIMENTAL
Intervention: Quazepam 30 mg
Number of subjects: 100
Study 6131825 — intervention group
Group type: EXPERIMENTAL
Intervention: Flunitrazepam 1 mg
Number of subjects: 100
Study 6131825 — intervention group
Group type: EXPERIMENTAL
Intervention: Flunitrazepam 2 mg
Number of subjects: 100
Study 6131825 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study 6131825 — intervention group
Group type: EXPERIMENTAL
Intervention: All active drugs (Quazepam and Flunitrazepam)
Number of subjects: 100
Study 6131825 — intervention group
Group type: EXPERIMENTAL
Intervention: All drugs tested (Quazepam and Flunitrazepam)
Number of subjects: 100
Study 31638878 — intervention group
Group type: EXPERIMENTAL
Intervention: Mobile texting aftercare intervention (Project ESQYIR)
Number of subjects: 80
Study 30922973 — intervention group
Group type: EXPERIMENTAL
Intervention: SomaScan Assay (SomaLogic) measuring 1305 proteins in serum and urine
Number of subjects: 60
Study 29227735 — intervention group
Group type: EXPERIMENTAL
Intervention: Running + plyometric group (RPG)
Number of subjects: 25
Study 29227735 — intervention group
Group type: COMPARATOR
Intervention: Running group (RG)
Number of subjects: 25
Study 27000058 — intervention group
Group type: EXPERIMENTAL
Intervention: Diet + Think Slim intervention (n=67)
Number of subjects: 134
Study 27000058 — intervention group
Group type: COMPARATOR
Intervention: Diet-only control group (n=67)
Number of subjects: 134
Study 25218717 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PLA)
Number of subjects: 12
Study 25218717 — intervention group
Group type: COMPARATOR
Intervention: Decaffeinated coffee (DECAF)
Number of subjects: 12
Study 25218717 — intervention group
Group type: COMPARATOR
Intervention: Caffeine (CAF)
Number of subjects: 12
Study 25218717 — intervention group
Group type: COMPARATOR
Intervention: Caffeine with decaffeinated coffee (COF)
Number of subjects: 12
Study 25218717 — intervention group
Group type: EXPERIMENTAL
Intervention: All treatments (PLA, DECAF, CAF, COF)
Number of subjects: 12
Study 21835151 — intervention group
Group type: EXPERIMENTAL
Intervention: Cardiac Resynchronization Therapy (CRT)
Number of subjects: 1520
Study 21835151 — intervention group
Group type: COMPARATOR
Intervention: Optimal Pharmacologic Therapy (OPT)
Number of subjects: 1520
Study 21142736 — intervention group
Group type: EXPERIMENTAL
Intervention: 810-nm diode laser treatment
Number of subjects: 35
Study 18097896 — intervention group
Group type: EXPERIMENTAL
Intervention: Intramuscular ergometrine (500 microg) during abdominal closure
Number of subjects: 50
Study 18097896 — intervention group
Group type: COMPARATOR
Intervention: Routine bolus dose of 5 units of oxytocin after delivery
Number of subjects: 50
Study 15650888 — intervention group
Group type: EXPERIMENTAL
Intervention: Walking at different speeds (0.5 to 1.7 m/s) with loads from 0 to 75% of body mass
Number of subjects: 10
Study 15650888 — intervention group
Group type: EXPERIMENTAL
Intervention: Walking at optimal speed of 1.3 m/s with a load up to 1/4 M(b)
Number of subjects: 10
Study 15650888 — intervention group
Group type: EXPERIMENTAL
Intervention: Walking at optimal speed of 1.06 m/s for net cost minimization
Number of subjects: 10
Study 12170143 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous MgSO(4) with carbogen inhalation
Number of subjects: 133
Study 12170143 — intervention group
Group type: COMPARATOR
Intervention: Carbogen inhalation
Number of subjects: 133
Study 10458241 — intervention group
Group type: EXPERIMENTAL
Intervention: vincristine, carmustine, melphalan, cyclophosphamide, and prednisone
Number of subjects: 101
Study 10458241 — intervention group
Group type: COMPARATOR
Intervention: melphalan and prednisone
Number of subjects: 101
Study 7853039 — intervention group
Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study 2893560 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural sufentanil 50 micrograms
Number of subjects: 0
Study 2893560 — intervention group
Group type: COMPARATOR
Intervention: Intramuscular buprenorphine 0.3 mg
Number of subjects: 0
Study 29536107 — intervention group
Group type: EXPERIMENTAL
Intervention: Didactic training plus video simulation (N = 43)
Number of subjects: 94
Study 29536107 — intervention group
Group type: COMPARATOR
Intervention: Didactic training (N = 51)
Number of subjects: 94
Study 27105893 — intervention group
Group type: EXPERIMENTAL
Intervention: Video dubbed by the surgeon
Number of subjects: 129
Study 27105893 — intervention group
Group type: EXPERIMENTAL
Intervention: Silent video
Number of subjects: 129
Study 27105893 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 129
Study 24012322 — intervention group
Group type: EXPERIMENTAL
Intervention: Real LTE RF‐EMF exposure for 30 minutes
Number of subjects: 18
Study 24012322 — intervention group
Group type: COMPARATOR
Intervention: Sham exposure (control)
Number of subjects: 18
Study 22492277 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive behavioral therapy
Number of subjects: 450
Study 22492277 — intervention group
Group type: EXPERIMENTAL
Intervention: Ibuprofen
Number of subjects: 450
Study 22492277 — intervention group
Group type: COMPARATOR
Intervention: No intervention (control)
Number of subjects: 450
Study 19464064 — intervention group
Group type: EXPERIMENTAL
Intervention: Bosentan 62.5 mg bid for four weeks (uptitrated to 125 mg bid thereafter)
Number of subjects: 54
Study 19464064 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 54
Study 19464064 — intervention group
Group type: EXPERIMENTAL
Intervention: Bosentan
Number of subjects: 54
Study 18413309 — intervention group
Group type: EXPERIMENTAL
Intervention: Diabetes in patients with preserved EF
Number of subjects: 7599
Study 18413309 — intervention group
Group type: EXPERIMENTAL
Intervention: Diabetes in patients with low EF
Number of subjects: 7599
Study 18413309 — intervention group
Group type: COMPARATOR
Intervention: Candesartan treatment
Number of subjects: 7599
Study 20054085 — intervention group
Group type: EXPERIMENTAL
Intervention: Live cows (Group A)
Number of subjects: 27
Study 20054085 — intervention group
Group type: COMPARATOR
Intervention: Breed'n Betsy (Group B)
Number of subjects: 27
Study 20054085 — intervention group
Group type: EXPERIMENTAL
Intervention: Live cows (intense training, Experiment 2)
Number of subjects: 27
Study 15901290 — intervention group
Group type: EXPERIMENTAL
Intervention: Levovist 1 g
Number of subjects: 40
Study 15901290 — intervention group
Group type: EXPERIMENTAL
Intervention: Sono Vue 1 mL
Number of subjects: 40
Study 11323581 — intervention group
Group type: EXPERIMENTAL
Intervention: Sandwich method (ligation-sclerotherapy-ligation)
Number of subjects: 94
Study 11323581 — intervention group
Group type: COMPARATOR
Intervention: Ligation alone
Number of subjects: 94
Study 11323581 — intervention group
Group type: EXPERIMENTAL
Intervention: Sandwich method
Number of subjects: 94
Study 9395700 — intervention group
Group type: EXPERIMENTAL
Intervention: Qigong therapy
Number of subjects: 44
Study 9395700 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapeutic touch (TT) therapy
Number of subjects: 44
Study 9395700 — intervention group
Group type: COMPARATOR
Intervention: Control group (nonbelievers)
Number of subjects: 44
Study 8388479 — intervention group
Group type: EXPERIMENTAL
Intervention: All-trans-retinoic acid (all-trans-RA) at a dose of 156 mg/m2 on day 28 and 78 mg/m2 on day 29.
Number of subjects: 6
Study 8388479 — intervention group
Group type: EXPERIMENTAL
Intervention: All-trans-retinoic acid (all-trans-RA) at a dose of 78 mg/m2 on day 28 and 156 mg/m2 on day 29.
Number of subjects: 6
Study 2445783 — intervention group
Group type: EXPERIMENTAL
Intervention: Postrotation experimental group (curriculum in developmental pediatrics)
Number of subjects: 161
Study 2445783 — intervention group
Group type: COMPARATOR
Intervention: Prerotation control group (no curriculum in developmental pediatrics)
Number of subjects: 161
Study 2445783 — intervention group
Group type: EXPERIMENTAL
Intervention: Subjective evaluations by residents and faculty preceptors
Number of subjects: 161
Study 11449752 — intervention group
Group type: EXPERIMENTAL
Intervention: Family-involved treatments
Number of subjects: 36
Study 11449752 — intervention group
Group type: EXPERIMENTAL
Intervention: Al-Anon facilitation and referral
Number of subjects: 36
Study 11449752 — intervention group
Group type: COMPARATOR
Intervention: Johnson intervention
Number of subjects: 36
Study 11449752 — intervention group
Group type: EXPERIMENTAL
Intervention: Community Reinforcement and Family Training
Number of subjects: 36
Study 11449752 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioral Couples Therapy (BCT)
Number of subjects: 36
Study 11449752 — intervention group
Group type: EXPERIMENTAL
Intervention: Disulfiram contract procedure
Number of subjects: 36
Study 11449752 — intervention group
Group type: EXPERIMENTAL
Intervention: Family systems and family disease approaches
Number of subjects: 36
Study 31477086 — intervention group
Group type: EXPERIMENTAL
Intervention: Online intervention as indicated prevention
Number of subjects: 0
Study 31477086 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive personalized modular outpatient treatment
Number of subjects: 0
Study 30563642 — intervention group
Group type: EXPERIMENTAL
Intervention: Esomeprazole
Number of subjects: 0
Study 30563642 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspirin
Number of subjects: 0
Study 30563642 — intervention group
Group type: EXPERIMENTAL
Intervention: Esomeprazole and Aspirin
Number of subjects: 0
Study 30563642 — intervention group
Group type: COMPARATOR
Intervention: Control group (placebo)
Number of subjects: 0
Study 27512051 — intervention group
Group type: EXPERIMENTAL
Intervention: TEXT ME text message intervention
Number of subjects: 710
Study 27512051 — intervention group
Group type: EXPERIMENTAL
Intervention: TEXT ME text message intervention + cardiac rehabilitation
Number of subjects: 710
Study 27512051 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control)
Number of subjects: 710
Study 24592906 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-ligating brackets
Number of subjects: 25
Study 24592906 — intervention group
Group type: COMPARATOR
Intervention: Conventional brackets
Number of subjects: 25
Study 22353804 — intervention group
Group type: EXPERIMENTAL
Intervention: MSI-H colon cancer (n=34)
Number of subjects: 223
Study 22353804 — intervention group
Group type: EXPERIMENTAL
Intervention: Beta2-Microglobulin mutations in MSI-H colon cancers (10 out of 34)
Number of subjects: 223
Study 22353804 — intervention group
Group type: COMPARATOR
Intervention: MSS colon cancer (n=189)
Number of subjects: 223
Study 20068432 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise interventions (aerobic, strength, combined); specific dosages and durations not available
Number of subjects: 80
Study 20068432 — intervention group
Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 80
Study 17103286 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound guided‐percutaneous drainage and i.v. antibiotics (ampicillin, cefuroxime, and metronidazole)
Number of subjects: 50
Study 17103286 — intervention group
Group type: COMPARATOR
Intervention: Antibiotics only
Number of subjects: 50
Study 14687173 — intervention group
Group type: EXPERIMENTAL
Intervention: Rabeprazole 10 mg twice daily
Number of subjects: 18
Study 14687173 — intervention group
Group type: COMPARATOR
Intervention: Rabeprazole 20 mg once daily
Number of subjects: 18